The Dividend Yield as of December 2024 (TTM) for iTeos Therapeutics, Inc. (ITOS) is 0%

According to iTeos Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

iTeos Therapeutics, Inc. (ITOS) Historical Dividend Yield (quarterly & annually)

How has ITOS Dividend Yield performed in the past?

The mean historical Dividend Yield of iTeos Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), ITOS's Dividend Yield was at its highest in in the March 2019 quarter at 0%. The Dividend Yield was at its lowest in in the March 2019 quarter at 0%.

iTeos Therapeutics, Inc. (ITOS) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of iTeos Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

iTeos Therapeutics, Inc. (ITOS) Average Dividend Yield

How has ITOS Dividend Yield performed in the past?

The current Dividend Yield of iTeos Therapeutics, Inc. (ITOS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

iTeos Therapeutics, Inc. (ITOS) Dividend Yield vs. Peers

How is ITOS’s Dividend Yield compared to its peers?

iTeos Therapeutics, Inc.’s Dividend Yield is less than Icosavax, Inc. (0%), less than Mirati Therapeutics, Inc. (0%), less than VectivBio Holding AG (0%), less than Annexon, Inc. (0%), less than Gracell Biotechnologies Inc. (0%), less than Theseus Pharmaceuticals, Inc. (0%), less than Monte Rosa Therapeutics, Inc. (0%), less than Design Therapeutics, Inc. (0%), less than Erasca, Inc. (0%), less than Apellis Pharmaceuticals, Inc. (0%), less than TScan Therapeutics, Inc. (0%), less than Terns Pharmaceuticals, Inc. (0%), less than Day One Biopharmaceuticals, Inc. (0%), less than Acumen Pharmaceuticals, Inc. (0%), less than Amylyx Pharmaceuticals, Inc. (0%), less than MoonLake Immunotherapeutics (0%), less than Revolution Medicines, Inc. (0%), less than Blueprint Medicines Corporation (0%), less than Sana Biotechnology, Inc. (0%), less than Kymera Therapeutics, Inc. (0%),

Build a custom stock screener for iTeos Therapeutics, Inc. (ITOS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like iTeos Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

iTeos Therapeutics, Inc. (ITOS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like iTeos Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.